Egypt approves emergency use of locally manufactured Sinovac/VACSERA COVID-19 vaccine


The Egyptian Drug Authority (EDA) granted the Sinovac/VACSERA COVID-19 vaccine an emergency use license after passing the required evaluation — the first locally produced vaccine to be greenlit for use in the country, the Egyptian government announced on Monday.

The manufacturing of Sinovac vaccine doses is part of an agreement signed between the Egyptian Holding Company for Biological Products and Vaccines (VACSERA) and the Chinese biopharmaceutical company Sinovac.

READ MORE  COVID-19 may cause this permanent side-effect - Researchers

In a press conference on Monday, Minister of Health Hala Zayed announced that the ministry will start distributing the Sinovac/VACSERA vaccine to vaccination centers nationwide starting Tuesday.

According to Zayed, VASCERA has already produced 15 million doses of the Sinovac vaccine and will continue to produce between 15 and 18.5 million doses per month with the aim of covering local and African needs.

Facebook Comments Box


Please enter your comment!
Please enter your name here